SCHEMBL17681531

SCHEMBL17681531

O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)c(CCc2ccccc2)c1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 18/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1959766 0.88 BCL2 (0.80) BCL2
SCHEMBL1541118 0.87 BCL2 (0.72) BCL2
SCHEMBL1957634 0.84 BCL2 (0.81) BCL2
SCHEMBL1541585 0.84 BCL2 (0.72) BCL2
SCHEMBL2830924 0.84 BCL2 (0.87) BCL2
SCHEMBL1957020 0.84 BCL2 (0.80) BCL2
SCHEMBL1955720 0.84 BCL2 (0.84) BCL2
SCHEMBL1540777 0.83 BCL2 (0.68) BCL2
SCHEMBL1955098 0.82 BCL2 (0.82) BCL2
SCHEMBL1955324 0.82 BCL2 (0.88) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315488-B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE INC. (US) 2016-04-19 — — US disclosed
Send feedback